A Retrospective Analysis from Western Romania Comparing the Treatment and Survivability of p16-Positive versus p16-Negative Oropharyngeal Cancer
- PMID: 38473308
- PMCID: PMC10930542
- DOI: 10.3390/cancers16050945
A Retrospective Analysis from Western Romania Comparing the Treatment and Survivability of p16-Positive versus p16-Negative Oropharyngeal Cancer
Abstract
Background: Oropharyngeal cancer is a global health concern due to its multifaceted nature. Recent molecular studies have linked p16 overexpression, associated with the human papillomavirus, to oropharyngeal cancer and its prognostic implications.
Materials and methods: This retrospective study in Western Romania examined 60 patients, categorizing them based on p16 biomarker status: 28 were p16 positive, and 32 were p16 negative. Statistical tests, including Fisher's exact and chi2, were used for analysis.
Results: Patients with p16-positive oropharyngeal cancer exhibited a better prognosis (3-year survival, p = 0.0477; midtreatment, p = 0.0349) and reported lower alcohol (p = 0.0046) and tobacco (p < 0.0001) use.
Conclusions: The study highlights the importance of p16 testing in oropharyngeal carcinoma diagnosis. It suggests modifying treatment approaches based on p16 status and underscores the differing prognoses associated with p16-positive and p16-negative cases.
Keywords: HPV; oropharyngeal cell carcinoma; p16 overexpression; radiotherapy.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Sitaru A.M., Flondor D., Dinu Ş., Horhat I.D., Iftode O.A., Poenaru M., Balica N.C., Baderca F., Georgescu D., Chioran D., et al. Laryngeal malignancies—Epidemiological data and particularities of the cases diagnosed in Western Romania (October 2016–July 2020) Rom. J. Morphol. Embryol. 2022;63:153–160. doi: 10.47162/RJME.63.1.16. - DOI - PMC - PubMed
-
- Melchers L.J., Mastik M.F., Cameron B.S., Dijk B.A.C.V., De Bock G.H., Laan B.F.A.M.V.D., Van Der Vegt B., Speel E.J.M., Roodenburg J.L.N., Witjes M.J.H., et al. Detection of HPV-associated oropharyngeal tumours in a 16-year cohort: More than meets the eye. Br. J. Cancer. 2015;112:1349–1357. doi: 10.1038/bjc.2015.99. - DOI - PMC - PubMed
-
- Ndiaye C., Mena M., Alemany L., Arbyn M., Castellsagué X., Laporte L., Bosch F.X., de Sanjosé S., Trottier H. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: A systematic review and meta-analysis. Lancet Oncol. 2014;15:1319–1331. doi: 10.1016/S1470-2045(14)70471-1. - DOI - PubMed
-
- Mogoantă C.A., Ciolofan M.S., Istrate-Ofițeru A.M., Mogoantă S.Ș., Roșu G.C., Anghelina F., Iovănescu G. HPV and Other Risk Factors Involved in Pharyngeal Neoplasm—Clinical and Morphopathological Correlations in the Southwestern Region of Romania. Pathogens. 2023;12:984. doi: 10.3390/pathogens12080984. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
